SavedAdd your journal

Journals / Sağlık Bilimlerinde Değer / 2023 / Cilt: 13 - Sayı: 1

Optic Coherence Tomography Findings in Hyperthyroid Patients without Ophthalmopathy

Oftalmopatisiz Hipertiroidik Hastalarda Optik Cohorens Tomografi Bulguları

Mehmet Tahir ESKİ
Kuddusi TEBERİK
Taha SEZER
Atilla ÖNMEZ
Pages
123–128
Publication Date
2023-01-20
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In terms of RT measurements, T500,T1000,T1500 and N1500 values were found to be lower in the HT group compared to the control group, and they were statistically significant (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim The aim of this study is to compare the choroidal, retinal, and peripapillary nerve fiber layer thickness of the patients diagnosed with hyperthyroidism but did not develop ophthalmopathy with the euthyroid patients.
📊
Key Findings & Data:Material and Methods: Thyroid stimulating hormone (TSH), freeT3 (fT3) and freeT4 (fT4) tests of the patients were analyzed.
💡
Conclusion & Impact:In terms of RT measurements, T500,T1000,T1500 and N1500 values were found to be lower in the HT group compared to the control group, and they were statistically significant (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hipertiroidi · retina kalınlığı · koroid kalınlığı

Abstract

Aim The aim of this study is to compare the choroidal, retinal, and peripapillary nerve fiber layer thickness of the patients diagnosed with hyperthyroidism but did not develop ophthalmopathy with the euthyroid patients. Material and Methods: Thyroid stimulating hormone (TSH), freeT3 (fT3) and freeT4 (fT4) tests of the patients were analyzed. Cases who came in with symptoms of hyperthyroidism and had a TSH lower than 0.5 mu/L were included to the study. Retinal thickness (RT), retinal nerve fiber layer (RNFL) thickness, and choroidal thickness (CT) were calculated by means of spectral domain optical coherence tomography. Results: A total of 82 participants, covering 40 (49%) hyperthyroid patients and 42 (51%) euthyroid healthy individuals, were examined. In terms of RT measurements, T500,T1000,T1500 and N1500 values were found to be lower in the HT group compared to the control group, and they were statistically significant (p

Özet

Amaç: Bu çalışmada, hipertiroidi tanısı olan ve oftalmopati gelişmemiş hastalardaki koroid, retina ve peripapiller sinir lifi tabakasının kalınlığını ötiroid hasta grubuyla karşılaştırmak amaçlanmıştır. Gereç ve Yöntemler: Hastaların serum tiroid stimülan hormon (TSH), serbest T3 (fT3), serbest T4 (fT4) değerleri incelendi. Hipertiroidi semptomları ile başvuran ve tetkiklerinde TSH; 0,5 mu/L’nin altında saptanan olgular çalışmaya dahil edildi. Spektral domain optik koherens tomografi ile retina kalınlığı (RT), retina sinir lifi tabakası (RSLT) kalınlığı ve koroid kalınlığı (CT) hesaplandı. Bulgular: Çalışmaya 40’ı (%49) hipertiroidi hastası (HT), 42’si (%51) ötiroidik sağlıklı bireyler olmak üzere toplamda 82 kişi dahil edildi. RT ölçümleri açısından T500, T1000, T1500 ve N1500 değerlerinin HT grupta kontrol grubuna göre daha düşük olduğu olduğu ve bunların istatistiksel olarak anlamlı olduğu görüldü (sırasıyla p

🔖

Cite This Article

ESKİ, M. T., TEBERİK, K., SEZER, T., ÖNMEZ, A. (2023). Optic Coherence Tomography Findings in Hyperthyroid Patients without Ophthalmopathy. Sağlık Bilimlerinde Değer, Cilt: 13 - Sayı: 1, 123–128. https://ajindex.com/articles/877993

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018; 14(5): 301-16. Mansourian AR. Metabolic pathways of tetraidothyronine and triidothyronine production by thyroid gland: a review of articles. Pak J Biol Sci. 2011; 14(1): 1-12.
  2. Liu ZW, Masterson L, Fish B, Jani P, Chatterjee K. Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy. Cochrane Database Syst Rev. 2015; 25(11): 1-7.
  3. Schmidt M, Voell M, Rahlff I, Dietlein M, Kobe C, Faust M, et al. Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto’s thyroiditis) treated with levothyroxine. Thyroid. 2008; 18: 755-60.
  4. Marino M, Ionni I, Lanzolla G, Sframeli A, Latrofa F, Rocchi R, et al. Orbital diseases mimicking graves’ orbitopathy: a long-standing challenge in differential diagnosis. J Endocrinol Invest. 2020; 43: 401-11.
  5. Levy J, Puterman M, Lifshitz T, Marcus M, Segal A, Monos T. Endoscopic orbital decompression for Graves’ ophthalmopathy. Isr Med Assoc J. 2004; 6(11): 673-6.
  6. Casini G, Marino M, Rubino M, Licari S, Covello G, Mazzi B, et al. Retinal, choroidal and optic disc analysis in patients with Graves’ disease with or without orbitopathy. Int Ophthalmol. 2020; 40(9): 2129-37.
  7. Kurt MM, Akpolat C, Evliyaoglu F, Yilmaz M, Ordulu F. Evaluation of retinal neurodegeneration and choroidal thickness in patients with ınactive graves’ ophthalmopathy. Klin Monbl Augenheilkd. 2021; 238(7): 797-802.
  8. Yıldırım G, Şahlı E, Alp MN. Evaluation of the effect of proptosis on choroidal thickness in graves’ ophthalmopathy. Turk J Ophthalmol. 2020; 50(4): 221-7.
  9. Fazil K, Ozturk Karabulut G, Alkin Z. Evaluation of choroidal thickness and retinal vessel density in patients with inactive Graves’ orbitopathy. Photodiagnosis Photodyn Ther. 2020; 32: 101898. Çalışkan S, Acar M, Gürdal C. Choroidal thickness in patients with graves’ ophthalmopathy. Curr Eye Res. 2017; 42(3): 484-90.
  10. Spaide RF, Koizumi H, Pozzoni MC, Pozonni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008; 146(4): 496-500.
  11. Bruscolini A, La Cava M, Gharbiya M, Sacchetti M, Restivo L, Nardella C, et al. Management of patients with graves’ disease and orbital ınvolvement: Role of spectral domain optical coherence tomography. J Immunol Res. 2018; 2018: 1454616. Teberik K, Eski MT, Doğan S, Pehlivan M, Kaya M. Ocular abnormalities in morbid o